Gynecology Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The report covers Global Gynecology Drug Companies and the market is Segmented by Therapeutics (Hormonal Therapy and Non-Hormonal Therapy), Indication (Gynecology Cancers, Menopausal Disorder, Polycystic Ovary Syndrome, Contraception, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.

Gynecology Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Gynecology Drugs Industry Overview

The gynecology drugs market is moderately competitive and consists of several major players. Some prominent players in the market are implementing various strategies, such as launching new products and making acquisitions to consolidate their market positions across the globe. The competitive landscape includes an analysis of a few international as well as local companies that hold the market shares and are well known, including Allergan Plc, Pfizer Inc, AbbVie Inc, TherapeuticsMD Inc, and Ferring Holding SA, among others.

Gynecology Drugs Market Leaders

  1. Ferring Holding SA

  2. TherapeuticsMD Inc.

  3. AbbVie Inc.

  4. Pfizer Inc.

  5. GSK plc

  6. *Disclaimer: Major Players sorted in no particular order
Gynecology Drugs Market Concentration